Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000968934 | SCV001116418 | likely benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004029936 | SCV003556335 | uncertain significance | not specified | 2022-04-08 | criteria provided, single submitter | clinical testing | The c.2054C>G (p.T685R) alteration is located in exon 10 (coding exon 9) of the PASK gene. This alteration results from a C to G substitution at nucleotide position 2054, causing the threonine (T) at amino acid position 685 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV000968934 | SCV005261972 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003905962 | SCV004720158 | likely benign | PASK-related disorder | 2021-02-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |